Partnering tabs - Therapy Areas " >Partnering tabs - Therapy Areas

Novartis is uniquely diversified across therapy areas with exposure to cutting-edge technology platforms. We have arguably the richest and broadest pipeline in the industry with more than 65 New Molecular Entities in development. Please select your therapy area of interest to connect to one of our specialist partnering professionals.

Seeking transformative immune-regulating or tolerance-inducing approaches to rebuild the immune system.

Enrico Funhoff portrait

Rico Funhoff

Contact me for partnerships before clinical PoC.

Contact

 

Patrick Mueller

Patrick Mueller

Contact me for partnerships after clinical PoC.

Contact

Interested in disruptive technologies and novel treatments addressing heart failure, cardiac arrhythmias and atherosclerosis.

Avi Spier portrait

 

Avi Spier

Contact me for partnerships before clinical PoC.

Contact

Mireia Gomez Angelats portrait

Mireia Gomez Angelats

Contact me for partnerships after clinical PoC.

Contact

Seeking first in class and well differentiated, best in class treatments for moderate-severe Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa, Vitiligo, Alopecia Areata and severe forms of Acne as well as curative treatments for rare skin diseases.

Enrico Funhoff portrait

 

Rico Funhoff

Contact me for partnerships before clinical PoC.

Contact

Patrick Mueller

Patrick Mueller

Contact me for partnerships after clinical PoC.

Contact

Seeking transformative approaches to address genetic diseases.

Adam Simpson portrait

Adam Simpson

Senior Director, Business Development (leads early-stage BD).

Contact me for early stage partnerships

 

Blue icon of a business woman

Elizabeth McMath

Associate Director, Global Search & Evaluation

Contact me for late stage partnerships after clinical PoC

Seeking new mechanisms of action and combination therapy partners for treating liver fibrosis and other non-viral liver diseases or promoting liver regeneration.

Bose Avirup portrait

 

Avirup Bose

Contact me for partnerships before clinical PoC.

Contact

Interested in disease modifying therapies and disruptive approaches displacing existing standard of care in diseases including obesity and other areas with high unmet need.

Avi Spier portrait

 

Avi Spier

Contact me for partnerships before clinical PoC.

Contact

Mireia Gomez Angelats portrait

Mireia Gomez Angelats

Contact me for partnerships after clinical PoC.

Contact

Seeking truly disease modifying treatments for OA which improve structure, function and pain as well as regenerative therapies for tendon diseases.

Dominic Ehrismann portrait

 

Dominic Ehrismann

Contact me for partnerships before clinical PoC.

Contact

Patrick Mueller

Patrick Mueller

Contact me for partnerships after clinical PoC.

Contact

Interested in disease modifying treatments for neurodegenerative diseases, refractory psychiatric disorders, multiple sclerosis and pediatric neurology.

Blue icon of a business woman

 

ChiChi Zhu

Contact me for partnerships before clinical PoC.

Contact

Emanuela Basaldella

Emanuela Basaldella

Contact me for partnerships after clinical PoC.

Contact

Seeking to develop and deliver life-changing medicines for diseases and conditions from front to back of the eye, enabled by data, transformative technologies, and partnerships.

Adam Feire portrait

 

Adam Feire

Contact me for partnerships before clinical PoC.

Contact

Dimitrios Lizos

Dimitrios Lizos

Contact me for partnerships after clinical PoC.

Contact

Interested in disease modifying treatments and renal indications with high unmet need.

Bose Avirup portrait

 

Avirup Bose

Contact me for partnerships before clinical PoC.

Contact

Mireia Gomez Angelats portrait

Mireia Gomez Angelats

Contact me for partnerships after clinical PoC.

Contact

We are looking for partners to expand our portfolio with innovative and potentially transformative agents with a primary focus in subspeciality respiratory (e.g. IPF, sarcoidosis, bronchiectasis), COPD, food allergy, life threatening hospital conditions (e.g. ARDS, BPD) and Asthma.

Dominic Ehrismann portrait

 

Dominic Ehrismann

Contact me for partnerships before clinical PoC.

Contact

Blue icon of a business man

Ken Shaw

Contact me for partnerships after clinical PoC.

Contact

Seeking projects with First in Class or Best in Class potential for moderate-severe Rheumatoid & Psoriatic Arthritis, Ankylosing Spondylitis, primary Sjoegren and Lupus with emphasis on oral treatments at par with biologics, or biologics with clear differentiation versus standard of care.

Enrico Funhoff portrait

 

Rico Funhoff

Contact me for partnerships before clinical PoC.

Contact

Patrick Mueller

Patrick Mueller

Contact me for partnerships after clinical PoC.

Contact

Seeking next generation therapies to prevent solid organs rejection, and extend graft life.

Enrico Funhoff portrait

 

Rico Funhoff

Contact me for partnerships before clinical PoC.

Contact

Patrick Mueller

Patrick Mueller

Contact me for partnerships after clinical PoC.

Contact

We accept that innovation happens outside of areas of interest- we are still prepared to discuss transformational areas we may have missed. We have a special team for you to talk with.

Blue icon of a business man

Ken Shaw

Contact me for partnerships before and after clinical PoC

Contact

Oncology - Partnering tab " >Oncology - Partnering tab

Oncology

Exploring opportunities in areas where Novartis has active efforts, such as breast and lung cancers, melanoma, renal cell carcinoma, and malignant hematology; and we seek to expand into other high-unmet need areas such as hepatocellular, pancreatic, colorectal, and prostate cancers and others. Our partnering teams are organized by stage of development (clinical stage or early), tumour type, or biology of the intervention.

Mark Temples portrait

Mark Temples

Breast and Gynaecological (Ovarian, Endometrial).

Contact

 

Ario Arabi Portrait

 

Ario Arabi

Lung and Melanoma.

Contact

Jesus Baena Portrait

Jesus Baena

Solid Tumours GI/GU.

Contact

 


Hematology

Seeking partners to significantly improve standard of care and cure patients in selected high unmet need in benign hematology diseases. The vision is to transform a number of disease specific classes not limited to hemophilia, complement disorders, anemia, sickle cell disease and thalassemia.

Laura Ripin portrait

Laura Ripin

Leukaemias and Myeloid Dysplastic Syndromes.

Contact

 

Markus Werner portrait

Markus Werner

Lymphomas and Multiple myelomas, CAR-T programs.

Contact

Reza Mazhari portrait

Reza Mazhari

Small molecules for Oncology and all pre PoC deals.

Contact

 

Bose Avirup portrait

Avirup Bose

Non Malignant Hemotology (Sickle Cell Disease).

Contact

 

Platform Collaborations - Partnering tab " >Platform Collaborations - Partnering tab

Seeking ways to transform patients’ lives by leading innovation in nuclear medicine and by investing in targeted Radioligand Therapy to treat advanced cancer – including advanced prostate cancer.
We are interested in partnerships that allow us to:

  • Innovate around targets and vectors
  • Identify or characterise new targets and receptor types specific to tumour cells or microenvironment.
  • Innovate or access New Chelators, Linkers and Ligands, Develop New Therapeutic or Diagnostic Isotopes or Leverage our developed supply and distribution network.
David Benathan

David Benathan

Contact

 

Alberto Villena portrait

Alberto Villena

Contact

 

Marcel Reichen

Marcel Reichen

Contact me for partnerships after clinical PoC.

Contact

Interested in biomarker and diagnostic technologies that are designed to optimize the efficiency, safety and therapeutic benefit of our drugs. Technologies may include genomic and proteomic testing as well as artificial intelligence driven solutions.

Guy Greiveldinger portrait

Guy Greiveldinger

Contact me for partnerships after clinical PoC.

Contact

Seeking partners such as NGOs, academic institutions, and companies to expand and accelerate our portfolio of drugs for neglected diseases, including tropical infectious diseases.


Charles Bailey

Charles Bailey

Contact me for partnerships.

Contact